跳至主要内容
临床试验/NCT04825548
NCT04825548已完成不适用

Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol

Aarhus University Hospital1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27
试验地点
1
主要终点
Number of patients with post thrombotic syndrome

研究概览

简要总结

Acute lymphoblastic leukemia (ALL) is the most common malignant disease in childhood. Today more than 90% of children and 75% of adults (18-45 years) survive ALL. The enzyme Asparaginase (Asp) is an indispensable part of the multiagent treatment of ALL.

Treatment related severe acute toxicities are common. Especially in teenagers and adults, thromboembolism is one of the most common acute toxicities and may result in post thrombotic syndrome (PTS) or pulmonary hypertension. The knowledge about these late effects is limited, including for ALL patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
1 Year 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Treated on the ALL2008 protocol for ALL. Had a DVT on treatment.

排除标准

  • 未提供

结局指标

主要结局

Number of patients with post thrombotic syndrome

时间窗: 01112020-01022023

次要结局

未报告次要终点

研究者

发起方
Aarhus University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Birgitte Klug Albertsen

M.D., PhD, Associate Professor

Aarhus University Hospital

研究点 (1)

Loading locations...

相似试验